Krishna Komanduri
Hematology & Oncology · Miami, FLNPI 1598850265
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $160,107 of the $187,229 with a category attached, or 85.5%. 17 manufacturers reported payments, led by Incyte Corporation at 36.0% of the total. Among hematology & oncology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 143 payments — averaging $1309.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$67K
- Gilead$32K
- Sanofi-aventis U.S. LLC$15K
- Sanofi$14K
- Genentech, Inc.$14K
- Janssen Scientific Affairs, LLC$9K
- plus $36K from 11 others
Across 2 payments — averaging $6760.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$8K
- F. Hoffmann-la Roche AG$5K
What the payments were for
- Consulting fees$160,10786%
- Speaking & faculty fees$7,8554%
- Travel & lodging$15,2478%
- Food & beverage$4,0202%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 77 | $67,309 |
| Gilead | 20 | $31,873 |
| Sanofi-aventis U.S. LLC | 8 | $14,688 |
| Sanofi | 2 | $14,376 |
| Genentech, Inc. | 2 | $14,040 |
| Janssen Scientific Affairs, LLC | 1 | $9,360 |
| Novartis | 7 | $9,074 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $8,860 |
| E.r. Squibb & Sons, L.L.C. | 3 | $6,891 |
| Johnson & Johnson | 3 | $3,190 |
| Kadmon Pharmaceuticals LLC | 2 | $3,176 |
| Rigel Pharmaceuticals, Inc. | 3 | $2,245 |
| National Marrow Donor Program | 9 | $2,043 |
| Merck | 1 | $32 |
| Bristol Myers Squibb | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$187,229 in reported general payments places this provider in the 95th percentile of 694 hematology & oncology providers in Florida.
Other hematology & oncology in Miami
- Steven FeinMiami$1M
- Srikanth NagallaMiami$639K
- Neil NagovskiMiami$530K
- Carl LandgrenMiami$517K
- Raja MudadMiami$422K
- George NahasMiami$364K
- Fernando de ZarragaMiami$333K
- Mikkael SekeresMiami$278K
- Estelamari RodriguezMiami$174K
- Gerald SoffMiami$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.